Eugene Jiang 13D and 13G filings for ABVC BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-07-15 4:30 pm Purchase |
2025-07-10 | 13D | ABVC BioPharma, Inc. ABVC |
Eugene Jiang | 3,102,265 18.500% |
153,850![]() (+5.22%) |
Filing |
2025-06-03 4:01 pm Purchase |
2025-05-13 | 13D | ABVC BioPharma, Inc. ABVC |
Eugene Jiang | 2,948,415 17.400% |
2,948,415![]() (New Position) |
Filing |